Peter Kolkhof

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Angiotensin Converting Enzyme

Muscular Dystrophy

Chronic Kidney Disease

Top Venues

International journal of molecular sciences

Journal of the American Heart Association

European heart journal

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ixchel Lima-Posada, Matthieu Soulie, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frédéric Jaisser
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association 13 (12) (2024)
Ixchel Lima-Posada, Matthieu Soulie, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frédéric Jaisser
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association 13 (12) (2024)
Ixchel Lima-Posada, Matthieu Soulie, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frédéric Jaisser
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association 13 (12) (2024)
Hiddo J Lambers Heerspink, Rajiv Agarwal, George L Bakris, David Z I Cherney, Carolyn S P Lam, Brendon L Neuen, Pantelis A Sarafidis, Katherine R Tuttle, Christoph Wanner, Meike D Brinker, Sara Dizayee, Peter Kolkhof, Patrick Schloemer, Paula Vesterinen, Vlado Perkovic, null null
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Ixchel Lima-Posada, Matthieu Soulie, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frédéric Jaisser
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association 13 (12) (2024)
Ixchel Lima-Posada, Matthieu Soulie, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frédéric Jaisser
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association 13 (12) (2024)
Muthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Alasdair Henderson, Meike Brinker, Peter Kolkhof, Patrick Schloemer, James Lay-Flurrie, Prabhakar Viswanathan, Carolyn Su Ping Lam, Michele Senni, Sanjiv J Shah, Carolyn S P Lam, Faiez Zannad, Ellen Burgess, Luis M Ruilope, Stefan D Anker, Bertram Pitt, Rajiv Agarwal, John Joseph Valentine McMurray, Scott D Solomon
Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART pooled analysis of cardiovascular, kidney, and mortality outcomes. Nature medicine (2024)
Ixchel Lima-Posada, Matthieu Soulie, Yohan Stephan, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Bertram Pitt, Peter Kolkhof, Paul Mulder, Frédéric Jaisser
Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association (2024)
Jack R Jerome, Devy Deliyanti, Varaporn Suphapimol, Peter Kolkhof, Jennifer L Wilkinson-Berka
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy. International journal of molecular sciences 24 (3) (2023)
Jack R Jerome, Devy Deliyanti, Varaporn Suphapimol, Peter Kolkhof, Jennifer L Wilkinson-Berka
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy. International journal of molecular sciences 24 (3) (2023)
Ixchel Lima-Posada, Yohan Stephan, Matthieu Soulie, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Peter Kolkhof, Frederic Jaisser, Paul Mulder
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction. International journal of molecular sciences 24 (3) (2023)
Ixchel Lima-Posada, Yohan Stephan, Matthieu Soulie, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Peter Kolkhof, Frederic Jaisser, Paul Mulder
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction. International journal of molecular sciences 24 (3) (2023)
Ixchel Lima-Posada, Yohan Stephan, Matthieu Soulie, Roberto Palacios Ramirez, Benjamin Bonnard, Lionel Nicol, Peter Kolkhof, Frederic Jaisser, Paul Mulder
Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction. International journal of molecular sciences 24 (3) (2023)
Jack R Jerome, Devy Deliyanti, Varaporn Suphapimol, Peter Kolkhof, Jennifer L Wilkinson-Berka
Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy. International journal of molecular sciences 24 (3) (2023)
Ly Tu, Raphaël Thuillet, Julie Perrot, Mina Ottaviani, Emy Ponsardin, Peter Kolkhof, Marc Humbert, Say Viengchareun, Marc Lombès, Christophe Guignabert
Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats. Hypertension (Dallas, Tex. : 1979) 79 (10) (2022)
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, Stefan D Anker, Ellen Burgess, Amer Joseph, Peter Kolkhof, Christina Nowack, Martin Gebel, Luis M Ruilope, George L Bakris, null null
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. European heart journal 43 (6) (2022)
Peter Kolkhof, Robert Lawatscheck, Gerasimos S Filippatos, George L Bakris
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone-Translational Aspects and Clinical Perspectives across Multiple Organ Systems. International journal of molecular sciences 23 (16) (2022)
Ulrich Kintscher, George L Bakris, Peter Kolkhof
Novel Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiorenal Disease. British journal of pharmacology (2021)
Jeovanna Lowe, Peter Kolkhof, Michael J Haupt, Kyra K Peczkowski, Neha Rastogi, J Spencer Hauck, Feni K Kadakia, Jonathan G Zins, Pierce C Ciccone, Suzanne Smart, Peter Sandner, Subha V Raman, Paul M L Janssen, Jill A Rafael-Fortney
Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy. ESC heart failure (2020)